🇺🇸 FDA
Pipeline program

Intravitreal Aflibercept Injection

2014-01-CRC

Approved small_molecule completed

Quick answer

Intravitreal Aflibercept Injection for Cystoid Macular Edema is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Cystoid Macular Edema
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials